Identification of instability elements in the 3′-untranslated region of the human thrombin-activatable fibrinolysis inhibitor mRNA

被引：0
|
作者：
Kuo, A [1 ]
Boffa, M [1 ]
Koschinsky, M [1 ]
机构：
[1] Queens Univ, Kingston, ON, Canada
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2006年 / 26卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E52 / E52
页数：1
相关论文
共 50 条
  • [1] Identification of a protein factor that regulates human thrombin-activatable fibrinolysis inhibitor mRNA stability
    Kuo, A. C. Y.
    Novakovic, D.
    Koschinsky, M. L.
    Boffa, M. B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 : 1 - 1
  • [2] Thrombin-activatable fibrinolysis inhibitor
    Marx, PF
    CURRENT MEDICINAL CHEMISTRY, 2004, 11 (17) : 2335 - 2348
  • [3] Identification of human thrombin-activatable fibrinolysis inhibitor in vascular and inflammatory cells
    Lin, Joellen H. H.
    Garand, Mathieu
    Zagorac, Branislava
    Schadinger, Steven L.
    Scipione, Corey
    Koschinsky, Marlys L.
    Boffa, Michael B.
    THROMBOSIS AND HAEMOSTASIS, 2011, 105 (06) : 999 - 1009
  • [4] Identification of functional thrombin-activatable fibrinolysis inhibitor in mice
    Marx, PF
    van Rossum, AGSH
    Bouma, BN
    Meijers, JCM
    THROMBOSIS AND HAEMOSTASIS, 1999, : 121 - 121
  • [5] Is there thrombin-activatable fibrinolysis inhibitor in saliva?
    Chopra, S.
    Friman, E.
    Krueger, C. W.
    Antovic, J. P.
    Naimi-Akbar, A.
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2020, 58 (09): : E33 - E37
  • [6] Identification and characterization of two thrombin-activatable fibrinolysis inhibitor isoforms
    Zhao, L
    Morser, J
    Bajzar, L
    Nesheim, M
    Nagashima, M
    THROMBOSIS AND HAEMOSTASIS, 1998, 80 (06) : 949 - 955
  • [7] The effects of hyperglycaemia on thrombin-activatable fibrinolysis inhibitor
    Verkleij, C. J. N.
    Nieuwdorp, M.
    Gerdes, V. E. A.
    Morgelin, M.
    Meijers, J. C. M.
    Marx, P. F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 392 - 392
  • [8] Characterization of mouse thrombin-activatable fibrinolysis inhibitor
    Marx, PF
    Wagenaar, GTM
    Reijerkerk, A
    Tiekstra, MJ
    van Rossum, AGSH
    Gebbink, MFBG
    Meijers, JCM
    THROMBOSIS AND HAEMOSTASIS, 2000, 83 (02) : 297 - 303
  • [9] Thrombin-activatable fibrinolysis inhibitor in hypothyroidism and hyperthyroxinaemia
    Verkleij, Chantal J. N.
    Stuijver, Danka J. F.
    van Zaane, Bregje
    Squizzato, Alessandro
    Brandjes, Dees P. M.
    Buller, Harry R.
    Meijers, Joost C. M.
    Gerdes, Victor E. A.
    THROMBOSIS AND HAEMOSTASIS, 2013, 109 (02) : 214 - 220
  • [10] The effects of hyperglycaemia on thrombin-activatable fibrinolysis inhibitor
    Verkleij, Chantal J. N.
    Nieuwdorp, Max
    Gerdes, Victor E. A.
    Morgelin, Matthias
    Meijers, Joost C. M.
    Marx, Pauline F.
    THROMBOSIS AND HAEMOSTASIS, 2009, 102 (03) : 460 - 468
12345